| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A magnetism/laser-auxiliary cascaded drug delivery to pulmonary carcinoma
|
Lin, Jialiang
|
|
|
10 |
8 |
p. 1549-1562
|
article
|
| 2 |
Author correction to ‘Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors’ [Acta Pharmaceutica Sinica B 8 (2018) 200–208]
|
Chen, Qing
|
|
|
10 |
8 |
p. 1586-1587
|
article
|
| 3 |
Bone marrow mesenchymal stem cells-derived exosomes for penetrating and targeted chemotherapy of pancreatic cancer
|
Zhou, Yu
|
|
|
10 |
8 |
p. 1563-1575
|
article
|
| 4 |
Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein
|
Dong, Wujun
|
|
|
10 |
8 |
p. 1576-1585
|
article
|
| 5 |
Conditional reprogramming: next generation cell culture
|
Wu, Xiaoxiao
|
|
|
10 |
8 |
p. 1360-1381
|
article
|
| 6 |
Cover Story
|
|
|
|
10 |
8 |
p. viii
|
article
|
| 7 |
Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy
|
Yao, Yuqin
|
|
|
10 |
8 |
p. 1453-1475
|
article
|
| 8 |
Discovery of the anti-angiogenesis effect of eltrombopag in breast cancer through targeting of HuR protein
|
Zhu, Yuying
|
|
|
10 |
8 |
p. 1414-1425
|
article
|
| 9 |
Discovery of [1,2,3]triazolo[4,5-d]pyrimidine derivatives as highly potent, selective, and cellularly active USP28 inhibitors
|
Liu, Zhenzhen
|
|
|
10 |
8 |
p. 1476-1491
|
article
|
| 10 |
Doxorubicin-loaded bacterial outer-membrane vesicles exert enhanced anti-tumor efficacy in non-small-cell lung cancer
|
Kuerban, Kudelaidi
|
|
|
10 |
8 |
p. 1534-1548
|
article
|
| 11 |
Gene therapy for neurodegenerative disorders: advances, insights and prospects
|
Chen, Wei
|
|
|
10 |
8 |
p. 1347-1359
|
article
|
| 12 |
Intracellular codelivery of anti-inflammatory drug and anti-miR 155 to treat inflammatory disease
|
Teng, Chao
|
|
|
10 |
8 |
p. 1521-1533
|
article
|
| 13 |
Limitation standard of toxic aconitines in Aconitum proprietary Chinese medicines using on-line extraction electrospray ionization mass spectrometry
|
Qiu, Zi-Dong
|
|
|
10 |
8 |
p. 1511-1520
|
article
|
| 14 |
Miltirone induces cell death in hepatocellular carcinoma cell through GSDME-dependent pyroptosis
|
Zhang, Xiaowei
|
|
|
10 |
8 |
p. 1397-1413
|
article
|
| 15 |
Novel opioid-neurotensin-based hybrid peptide with spinal long-lasting antinociceptive activity and a propensity to delay tolerance development
|
Frączek, Karolina
|
|
|
10 |
8 |
p. 1440-1452
|
article
|
| 16 |
Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
|
Wang, Biao
|
|
|
10 |
8 |
p. 1492-1510
|
article
|
| 17 |
Recent progress of hypoxia-modulated multifunctional nanomedicines to enhance photodynamic therapy: opportunities, challenges, and future development
|
Sun, Yixin
|
|
|
10 |
8 |
p. 1382-1396
|
article
|
| 18 |
Table of Contents
|
|
|
|
10 |
8 |
p. iii-viii
|
article
|
| 19 |
ZDHHC12-mediated claudin-3 S-palmitoylation determines ovarian cancer progression
|
Yuan, Meng
|
|
|
10 |
8 |
p. 1426-1439
|
article
|
Journal description